Heparin, heparin fractions, and the atherosclerotic process.
D000818:Animals; D001161:Arteriosclerosis / Q000188:drug therapy / Q000503:physiopathology*; D001777:Blood Coagulation / Q000187:drug effects; D001792:Blood Platelets / Q000187:drug effects / Q000502:physiology; D001808:Blood Vessels / Q000187:drug effects / Q000502:physiology; D002455:Cell Division / Q000187:drug effects; D003167:Complement Activation / Q000187:drug effects; D004727:Endothelium / Q000187:drug effects / Q000502:physiology; D011464:Epoprostenol / Q000502:physiology; D005342:Fibrinolysis / Q000187:drug effects; D006493:Heparin / Q000494:pharmacology* / Q000627:therapeutic use; D008055:Lipids / Q000097:blood; D008071:Lipoprotein Lipase / Q000378:metabolism; D008074:Lipoproteins / Q000378:metabolism; D008075:Lipoproteins, HDL / Q000097:blood; D008264:Macrophages / Q000187:drug effects; D009131:Muscle, Smooth, Vascular / Q000166:cytology; D010101:Oxygen Consumption / Q000187:drug effects; D010974:Platelet Aggregation / Q000187:drug effects; D013917:Thrombin / Q000037:antagonists & inhibitors; D014280:Triglycerides / Q000097:blood
D008055:Lipids; D008074:Lipoproteins; D008075:Lipoproteins, HDL; D014280:Triglycerides; D006493:Heparin; D011464:Epoprostenol; D008071:Lipoprotein Lipase; D013917:Thrombin